The Latest Breaking News from Vertex Pharmaceuticals

Vertex Pharmaceuticals has outperformed the broader market in 2024 but Wall Street analysts remain cautiously bullish about the stock's potential.

The best mutual funds spurned Nvidia and Microsoft last month. They got up and went to GoDaddy and these builders.

Vertex Pharmaceuticals will pay $4.9 billion to acquire Alpine Immune Sciences. Alpine stock rocketed almost 21% on rumors of the deal.

S&P 500 stocks Lennar, Vertex Pharmaceuticals and Royal Caribbean lead this list of five stocks trading around buy points.

Vertex is the IBD Stock Of The Day. VRTX stock bounced off its 50-day line as investors watch for the first sales of its gene-editing drug.

Vertex Pharmaceuticals just released data from its experimental drug to relieve pain, with no risk of addiction and very few side effects. This opioid alternative could give Vertex - already a powerhouse in the cystic fibrosis segment - another blockbuster drug to add to its portfolio.

The Dow Jones hit a record high while the S&P 500, Nasdaq and Russell 2000 set 2023 highs as the Fed signaled multiple rate cuts next year.

What you need to know… The S&P 500 Index ($SPX ) (SPY ) is up +1.16%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +1.05%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +1.2%. Stocks are surging this afternoon, with the S&P 500 and...

What you need to know… The S&P 500 Index ($SPX ) (SPY ) today is up +0.13%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.06%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.30%. Stocks this morning are mixed, with the S&P 500...